Free Trial

Addus HomeCare Co. (NASDAQ:ADUS) Shares Purchased by Principal Financial Group Inc.

Addus HomeCare logo with Medical background

Principal Financial Group Inc. lifted its stake in Addus HomeCare Co. (NASDAQ:ADUS - Free Report) by 17.5% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 505,853 shares of the company's stock after buying an additional 75,409 shares during the period. Principal Financial Group Inc. owned approximately 2.79% of Addus HomeCare worth $67,293,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds have also added to or reduced their stakes in the company. Texas Permanent School Fund Corp increased its position in Addus HomeCare by 0.6% during the 2nd quarter. Texas Permanent School Fund Corp now owns 14,089 shares of the company's stock valued at $1,636,000 after purchasing an additional 82 shares during the period. Arizona State Retirement System grew its position in shares of Addus HomeCare by 2.0% during the 2nd quarter. Arizona State Retirement System now owns 4,543 shares of the company's stock valued at $527,000 after acquiring an additional 87 shares during the period. UMB Bank n.a. grew its stake in Addus HomeCare by 64.2% during the second quarter. UMB Bank n.a. now owns 225 shares of the company's stock valued at $26,000 after acquiring an additional 88 shares in the last quarter. Inspire Investing LLC boosted its stake in Addus HomeCare by 3.3% during the third quarter. Inspire Investing LLC now owns 3,111 shares of the company's stock valued at $414,000 after buying an additional 100 shares during the period. Finally, New York State Teachers Retirement System grew its position in Addus HomeCare by 1.2% during the third quarter. New York State Teachers Retirement System now owns 8,510 shares of the company's stock worth $1,132,000 after buying an additional 100 shares in the last quarter. 95.35% of the stock is owned by institutional investors.

Addus HomeCare Trading Up 1.4 %

Shares of Addus HomeCare stock traded up $1.80 during trading hours on Friday, reaching $131.40. The stock had a trading volume of 473,672 shares, compared to its average volume of 134,800. The stock's 50 day moving average is $125.86 and its 200 day moving average is $125.07. Addus HomeCare Co. has a twelve month low of $85.94 and a twelve month high of $136.12. The firm has a market capitalization of $2.38 billion, a PE ratio of 30.07, a PEG ratio of 2.11 and a beta of 1.01.

Addus HomeCare (NASDAQ:ADUS - Get Free Report) last issued its earnings results on Monday, November 4th. The company reported $1.30 EPS for the quarter, beating analysts' consensus estimates of $1.28 by $0.02. Addus HomeCare had a net margin of 6.50% and a return on equity of 9.62%. The business had revenue of $289.80 million during the quarter, compared to analysts' expectations of $289.42 million. During the same period in the prior year, the business earned $1.03 earnings per share. The company's quarterly revenue was up 7.1% compared to the same quarter last year. As a group, sell-side analysts predict that Addus HomeCare Co. will post 4.59 earnings per share for the current year.

Analyst Ratings Changes

ADUS has been the subject of several analyst reports. Oppenheimer upped their price target on shares of Addus HomeCare from $140.00 to $145.00 and gave the company an "outperform" rating in a research report on Monday, September 23rd. Stephens boosted their price target on Addus HomeCare from $143.00 to $145.00 and gave the stock an "overweight" rating in a research report on Wednesday, November 6th. JMP Securities started coverage on shares of Addus HomeCare in a research note on Monday, December 16th. They set an "outperform" rating and a $150.00 target price on the stock. KeyCorp initiated coverage on shares of Addus HomeCare in a research report on Friday, October 11th. They set an "overweight" rating and a $150.00 price objective for the company. Finally, Citizens Jmp raised Addus HomeCare to a "strong-buy" rating in a research report on Monday, December 16th. One equities research analyst has rated the stock with a sell rating, nine have assigned a buy rating and two have given a strong buy rating to the company. According to MarketBeat, Addus HomeCare has an average rating of "Buy" and an average price target of $133.67.

Get Our Latest Analysis on ADUS

Insider Activity at Addus HomeCare

In other Addus HomeCare news, EVP Roberton James Stevenson sold 2,250 shares of the firm's stock in a transaction on Monday, December 9th. The stock was sold at an average price of $121.00, for a total transaction of $272,250.00. Following the completion of the sale, the executive vice president now owns 10,217 shares of the company's stock, valued at $1,236,257. This trade represents a 18.05 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO R Dirk Allison sold 12,500 shares of the business's stock in a transaction dated Monday, November 25th. The shares were sold at an average price of $123.16, for a total transaction of $1,539,500.00. Following the completion of the sale, the chief executive officer now owns 141,897 shares in the company, valued at approximately $17,476,034.52. This trade represents a 8.10 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 4.60% of the stock is currently owned by insiders.

About Addus HomeCare

(Free Report)

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.

Featured Stories

Institutional Ownership by Quarter for Addus HomeCare (NASDAQ:ADUS)

Should You Invest $1,000 in Addus HomeCare Right Now?

Before you consider Addus HomeCare, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Addus HomeCare wasn't on the list.

While Addus HomeCare currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Goldman Sachs’ 2025 Market Outlook: Top 3 Stock Picks
7 Stocks to Benefit From Trump’s Tariffs in 2025
Investing in Quantum Computing: Is Rigetti the Stock to Watch?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines